How do you pay?

How to pay the least

Ask for the cash price

Envarsus XR

Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you.

  1. Ask your pharmacy for Envarsus XR’s cash price, and one or two other pharmacies too.
  2. Envarsus XR’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameEnvarsus XR
Authorized generictacrolimus
Regular generictacrolimus
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Other forms onlyAsk your doctor
Same as Envarsus XR?
The original
–
–

Brand nameThe maker’s card

ENVARSUS XR $0 Copay Card

Savings card from Veloxis Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

The card takes up to $9,200 a year off your co-pay.

Sign up on envarsusxr.com 

Or call 1-855-591-9134.

In the maker’s words

“Pay as little as $0 for ENVARSUS XR…”

From the maker’s offer on envarsusxr.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Envarsus XR itself, from the same company, sold without the brand name, and usually for less. For now Envarsus XR is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ENVARSUS XR is a calcineurin-inhibitor immunosuppressant indicated for:

  • The prophylaxis of organ rejection in de novo kidney transplant patients in combination with other immunosuppressants
  • The prophylaxis of organ rejection in kidney transplant patients converted from tacrolimus immediate-release formulations in combination with other immunosuppressants

Source: the FDA label for Envarsus XR (Veloxis Pharmaceuticals, Inc), February 26, 2025. Full label on DailyMed 

Good to know